2Law MR, Wald HJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta - analysis. BMJ,2003,326:1 423-1 429.
3Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): muhicentre randomised placebo - controlled trial. Lancet, 2004, 364:685-696.
1Heart protection study collaborative Group. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals:a randomized placebo-controlled trial. Lancet ,2002:360:7-22.
2Perdersen TR. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease :the Scandinavian simvastatin Survival Study (4S). Lancet ,1994,344:1383-1389.
3Expert panel on Detection. Evaluation and Treatment of High Blood cholesterol in Adults. Excutive Summary of the Third Report of the National cholesterol Education Program(NCEP) Expert pane/on Detection,Evaluation,and Treatment of High Blood cholesterol i
4Aronow HD, Topol EJ, Roe MT, et al. Effect of lipid-lowing therapy on early mortality after acute coronary syndromes: an observational study. Lancet, 2001, 357 :1063-1068.
5Waters DD, Early pharmacologic intervention and plague stability in acute coronary syndrome. Am J Cardial, 2001, 88(8A): 30k-36k.
6Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med, 1996;335(14): 1001～1009
